Candid Health
+118%
est. 2Y upside i
Candid Health is building a modern medical payments platform that enables healthcare providers to focus on delivering high-quality, affordable and accessible care, rather than spending half their time figuring out how to get paid by insurance.
Rank
#297
Sector
Healthcare Technology
Est. Liquidity
~3Y
Data Quality
Data: MediumCandid Health offers significant upside potential (118% expected) driven by 250% YoY growth and a massive TAM, but faces high incumbent competition and a dilutive preference stack.
Last updated: July 19, 2026
Candid Health achieves IPO within 2 years, maintaining strong growth and expanding margins; exit multiple holds at 7x forward revenue, but stage cap limits upside to 200%. Projected revenue $415M supports $2.9B exit, capped at $1.35B.
Candid Health continues high growth but faces competition from incumbents; multiple converges to 5x forward revenue, implying $2.075B exit. After preference and dilution, common stock upside ~251%.
Incumbent competition intensifies, slowing growth to 100% YoY in year 1 and 50% in year 2; multiple compresses to 3x on $180M revenue, exit $540M. After preference and dilution, common stock loses ~22%.
Preference Stack Risk
highFunding Intensity
22%Total preferred stock of $99.5M represents 22.1% of current $450M valuation, posing significant overhang for common stock in downside scenarios.
Dilution Risk
highWith $99.5M total funding and high burn rate, Candid Health may need additional capital within 24 months, diluting common equity by ~20%.
Secondary Liquidity
noneNo secondary market observed; employees likely cannot sell shares until liquidity event.
Engineering — 16 roles
- AI/ML Engineer · New York City
- AI/ML Engineer (Senior) · San Francisco
- BI (Analytics) Engineer · San Francisco
- +13 more →
People — 4 roles
- Business Recruiter · San Francisco (CA), Denver (CO), New York (NY)
- People Operations · San Francisco (CA), Denver (CO), New York (NY)
- Recruiter (Engineering) · San Francisco (CA), Denver (CO), New York (NY)
- +1 more →
Sales — 4 roles
- Enterprise Account Executive · Remote (USA)
- Head of Sales Operations · Remote (USA)
- Head of Solutions Consulting · Remote (USA)
- +1 more →
Billing Team — 3 roles
- EDI Enrollments Specialist · Remote (USA)
- Medical Biller · Remote (USA)
- Payment Posting Specialist · Remote (USA)
Delivery / Customer Operations — 2 roles
- Customer Strategy & Operations · San Francisco
- Customer Support · San Francisco (CA), Denver (CO), New York (NY)
Finance — 2 roles
- Controller · San Francisco (CA), Denver (CO), New York (NY)
- Finance & Strategy Lead · San Francisco (CA), Denver (CO), New York (NY)
Marketing — 2 roles
- Account Based Marketing Manager · San Francisco (CA), Denver (CO), New York (NY)
- Marketing Operations Manager · San Francisco (CA), Denver (CO), New York (NY)
Design — 1 role
- Senior Product Designer · San Francisco
Facilities — 1 role
- Office Administrator · New York City
Leadership Overhead — 1 role
- Revenue Cycle Management / RCM Lead (Director Level) · Remote (USA)
Legal — 1 role
- Associate General Counsel · San Francisco (CA), Denver (CO), New York (NY)
Product — 1 role
- Senior Product Manager · San Francisco (CA), Denver (CO), New York (NY)
Last updated: March 10, 2026
Questions to Ask at the Interview
Strategic questions based on Candid Health's data — designed to show you've done your homework.
- 1
“How does Candid Health plan to defend against incumbent AI integration from R1 RCM and Change Healthcare?”
- 2
“What is the unit economics per provider, and how does the percentage-of-collections model scale with larger clients?”
- 3
“What is the expected timeline to liquidity, and does the company consider secondary sales for employees?”
Community
Valuation Sentiment
Our model estimates +118% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.